
Chihon Biotechnology
Found in 2003, Chihon Biotechnology has grown into a leading manufacturer of Nisin and Natamycin. Our unique highly concentrated Nisin has much lower sodium chloride (90% less). We also produce lauroyl arginine ethyl (LAE), ε -Polylysine and other preservatives. Our R&D is always willing to support our customers with their formulation issues. Our office/warehouse is Chicago and offers excellent customer service and timely delivery.
Documents Up to Date
Catalog
Documents
Lauryl-L-arginine ethyl ester monohydrochloride ( LAE) is an antimicrobial of the cationic surfactant.
Documents Up to Date
Documents
-
Allergens
(visible)
Click to download A -
Country of origin
(visible)
Click to download COO -
Item questionnaire
(visible)
Click to download IQ -
Nutrition
(visible)
Click to download N -
SDS (Safety Data Sheet)
(visible)
Click to download SDS -
Suitability requirements
(visible)
Click to download SR -
COA template
(not added) COA -
Product specification
(not added) PS
Natamycin is a natural preservative produced by fermentation of Streptomyces natalensis. It meets USP and EU standards.
Documents Up to Date
Documents
Nisin is a natural antibacterial, which is a polypeptide produced by strains of ‘Lactococcus lactis’ subsp ‘lactis’.
Documents Up to Date
Documents
ε-Polylysine is a natural preservative. It is used commercially in Japan, Korea and in imported items sold in the United States. The use of polylysine is common in food applications such as boiled rice, cooked vegetables, soups, noodles and seafoods.
Documents Up to Date
Locations
Location name | Address |
---|---|
Chihon Biotechnology - Corporate | 2772 Golfview Rd, Suite B Naperville, IL 60563 USA |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergen Control Policy | Chihon Biotechnology - Corporate | Allergen Control Policy.pdf | 10/20/2024 | 10/20/2026 |
GFSI Audit Report | Chihon Biotechnology - Corporate | Audit Report.pdf | 8/26/2022 | 8/5/2025 |
Bioterrorism Letter | Chihon Biotechnology - Corporate | Bioterrorism Letter.pdf | 10/20/2024 | 10/20/2026 |
FDA Registration | Chihon Biotechnology - Corporate | FDA registration 2024 Chihon.pdf | 10/22/2024 | 12/31/2026 |
Insurance | Chihon Biotechnology - Corporate | Insurance Allied.pdf | 4/29/2025 | 4/29/2026 |
GFSI Certificate | Chihon Biotechnology - Corporate | ISO22000.JPG | 10/20/2022 | 8/5/2025 |
Letter of Guarantee | Chihon Biotechnology - Corporate | Letter of Guarantee.pdf | 10/20/2024 | 10/20/2026 |
Recall/Emergency/Contact List | Chihon Biotechnology - Corporate | Recal Emergency Contact List.pdf | 10/20/2024 | 10/20/2025 |
Supplier Questionnaire | Chihon Biotechnology - Corporate | Supplier Questionnaire.pdf | 10/22/2024 | 10/22/2026 |